Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Nov;72(5):1658–1671. doi: 10.1172/JCI111125

Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells.

M E Gerritsen, C D Cheli
PMCID: PMC370454  PMID: 6415116

Abstract

Isolated microvessels and isolated and cultured microvessel endothelial cells were prepared from rabbit cardiac muscle. Pathways of arachidonic acid metabolism were determined by measurement of exogenous substrate utilization [( 1-14C]arachidonic acid incorporation and release from intact tissue and cells; [1-14C]prostaglandin H2 (PGH2) metabolism by broken cell preparations) and by quantification of endogenous products (immunoreactive 6-keto-prostaglandin F1 alpha (PGF1 alpha) and prostaglandin E (PGE) release) by selective radioimmunoassay. Rabbit coronary microvessels and derived microvascular endothelial cells (RCME cells) synthesized two major products of the cyclooxygenase pathway: 6-keto-PGF1 alpha (hydrolytic product of prostaglandin I2) and PGE2. A reduced glutathione requiring PGH-E isomerase was demonstrated in coronary microvessels and RCME cells, but not in rabbit circumflex coronary artery or aorta. In addition, a minor amount of a compound exhibiting similar characteristics to 6-keto-PGE1 was found to be produced by microvessels and RCME cells. Measurement of endogenously released prostaglandins indicated that under basal and stimulated conditions, PGE release exceeded that of 6-keto-PGF1 alpha. Microvessels and microvessel endothelial cells derived from cardiac muscle of rabbit exhibit pathways of arachidonate metabolism that are different from those of many large blood vessels and derived endothelial cells.

Full text

PDF
1658

Images in this article

1662Image
on p.1662
1662Image
on p.1662
1662Image
on p.1662
1663Image
on p.1663
1663Image
on p.1663
1664Image
on p.1664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ager A., Gordon J. L., Moncada S., Pearson J. D., Salmon J. A., Trevethick M. A. Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J Cell Physiol. 1982 Jan;110(1):9–16. doi: 10.1002/jcp.1041100103. [DOI] [PubMed] [Google Scholar]
  2. Allen J. E., Rasmussen H. Human red blood cells: prostaglandin E2, epinephrine, and isoproterenol alter deformability. Science. 1971 Oct 29;174(4008):512–514. doi: 10.1126/science.174.4008.512. [DOI] [PubMed] [Google Scholar]
  3. Azizkhan R. G., Azizkhan J. C., Zetter B. R., Folkman J. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med. 1980 Oct 1;152(4):931–944. doi: 10.1084/jem.152.4.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Belch J. J., Lowe D. G., Drummond M. M., Forbes C. D., Prentice C. R. Prostacyclin reduces red cell deformability. Thromb Haemost. 1981 Apr 30;45(2):189–189. [PubMed] [Google Scholar]
  5. Bourgain R. H. Inhibition of PGI2 (prostacyclin) synthesis in the arterial wall enhances the formation of white platelet thrombi in vivo. Haemostasis. 1978;7(4):252–255. doi: 10.1159/000214266. [DOI] [PubMed] [Google Scholar]
  6. Brendel K., Meezan E., Carlson E. C. Isolated brain microvessels: a purified, metabolically active preparation from bovine cerebral cortex. Science. 1974 Sep 13;185(4155):953–955. doi: 10.1126/science.185.4155.953. [DOI] [PubMed] [Google Scholar]
  7. Brody M. J., Kadowitz P. J. Prostaglandins as modulators of the autonomic nervous system. Fed Proc. 1974 Jan;33(1):48–60. [PubMed] [Google Scholar]
  8. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  9. Chang W. C., Murota S. I., Nakao J., Orimo H. Age-related decrease in prostacyclin biosynthetic activity in rat aortic smooth muscle cells. Biochim Biophys Acta. 1980 Oct 6;620(1):159–166. [PubMed] [Google Scholar]
  10. Coene M. C., Van Hove C., Claeys M., Herman A. G. Arachidonic acid metabolism by cultured mesothelial cells. Different transformations of exogenously added and endogenously. Biochim Biophys Acta. 1982 Mar 12;710(3):437–445. doi: 10.1016/0005-2760(82)90127-8. [DOI] [PubMed] [Google Scholar]
  11. Davison P. M., Bensch K., Karasek M. A. Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. J Invest Dermatol. 1980 Oct;75(4):316–321. doi: 10.1111/1523-1747.ep12530941. [DOI] [PubMed] [Google Scholar]
  12. DeBault L. E., Kahn L. E., Frommes S. P., Cancilla P. A. Cerebral microvessels and derived cells in tissue culture: isolation and preliminary characterization. In Vitro. 1979 Jul;15(7):473–487. doi: 10.1007/BF02618149. [DOI] [PubMed] [Google Scholar]
  13. Ellis E. F., Wei E. P., Kontos H. A. Vasodilation of cat cerebral arterioles by prostaglandins D2, E2, G2, and I2. Am J Physiol. 1979 Sep;237(3):H381–H385. doi: 10.1152/ajpheart.1979.237.3.H381. [DOI] [PubMed] [Google Scholar]
  14. Folkman J., Haudenschild C. C., Zetter B. R. Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5217–5221. doi: 10.1073/pnas.76.10.5217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gecse A., Ottlecz A., Mezei Z., Telegdy G., Joó F., Dux E., Karnushina I. Prostacyclin and prostaglandin synthesis in isolated brain capillaries. Prostaglandins. 1982 Mar;23(3):287–297. doi: 10.1016/0090-6980(82)90074-0. [DOI] [PubMed] [Google Scholar]
  16. Gerritsen M. E. PGD2 formation in the vasculature: characteristics of rat tail vein prostaglandin endoperoxide-D isomerase. Prostaglandins. 1983 Jan;25(1):105–120. doi: 10.1016/0090-6980(83)90140-5. [DOI] [PubMed] [Google Scholar]
  17. Gerritsen M. E., Parks T. P., Printz M. P. Prostaglandin endoperoxide metabolism by bovine cerebral microvessels. Biochim Biophys Acta. 1980 Aug 11;619(2):196–206. doi: 10.1016/0005-2760(80)90068-5. [DOI] [PubMed] [Google Scholar]
  18. Gerritsen M. E., Printz M. P. Prostaglandin D synthase in microvessels from the rat cerebral cortex. Prostaglandins. 1981 Oct;22(4):553–566. doi: 10.1016/0090-6980(81)90065-4. [DOI] [PubMed] [Google Scholar]
  19. Gerritsen M. E., Printz M. P. Prostaglandin E2 synthesis in pigeon aorta: comparison of atherosclerosis-resistant (Show Racer) and atherosclerosis-prone (White Carneau) breeds. Artery. 1980;8(1):56–62. [PubMed] [Google Scholar]
  20. Gerritsen M. E., Printz M. P. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Circ Res. 1981 Nov;49(5):1152–1163. doi: 10.1161/01.res.49.5.1152. [DOI] [PubMed] [Google Scholar]
  21. Goehlert U. G., Ng Ying Kin N. M., Wolfe L. S. Biosynthesis of prostacyclin in rat cerebral microvessels and the choroid plexus. J Neurochem. 1981 Mar;36(3):1192–1201. doi: 10.1111/j.1471-4159.1981.tb01718.x. [DOI] [PubMed] [Google Scholar]
  22. Granström E., Kindahl H. Radioimmunoassay of prostaglandins and thromboxanes. Adv Prostaglandin Thromboxane Res. 1978;5:119–210. [PubMed] [Google Scholar]
  23. Hamberg M., Samuelsson B. On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J Biol Chem. 1967 Nov 25;242(22):5329–5335. [PubMed] [Google Scholar]
  24. Hedqvist P. Actions of prostacyclin (PGI2) on adrenergic neuroeffector transmission in the rabbit kidney. Prostaglandins. 1979 Feb;17(2):249–258. doi: 10.1016/0090-6980(79)90045-5. [DOI] [PubMed] [Google Scholar]
  25. Hedqvist P. Basic mechanisms of prostaglandin action on autonomic neurotransmission. Annu Rev Pharmacol Toxicol. 1977;17:259–279. doi: 10.1146/annurev.pa.17.040177.001355. [DOI] [PubMed] [Google Scholar]
  26. Hensby C. N. Reduction of prostaglandin E2 to prostaglandin F2alpha by an enzyme in sheep blood. Biochim Biophys Acta. 1974 Apr 26;348(1):145–154. doi: 10.1016/0005-2760(74)90100-3. [DOI] [PubMed] [Google Scholar]
  27. Isakson P. C., Raz A., Needleman P. Selective incorporation of 14C-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to 14C-prostaglandins. Prostaglandins. 1976 Nov;12(5):739–748. doi: 10.1016/0090-6980(76)90049-6. [DOI] [PubMed] [Google Scholar]
  28. Korbut R., Moncada S. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy. Thromb Res. 1978 Sep;13(3):489–500. doi: 10.1016/0049-3848(78)90134-2. [DOI] [PubMed] [Google Scholar]
  29. Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  30. Maurer P., Moskowitz M. A., Levine L., Melamed E. The synthesis of prostaglandins by bovine cerebral microvessels. Prostaglandins Med. 1980 Mar;4(3):153–161. doi: 10.1016/0161-4630(80)90077-4. [DOI] [PubMed] [Google Scholar]
  31. Messina E. J., Weiner R., Kaley G. Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat. Circ Res. 1975 Oct;37(4):430–437. doi: 10.1161/01.res.37.4.430. [DOI] [PubMed] [Google Scholar]
  32. Messina E. J., Weiner R., Kaley G. Microcirculatory effects of prostaglandins E1, E2, and A1 in the rat mesentery and cremaster muscle. Microvasc Res. 1974 Jul;8(1):77–89. doi: 10.1016/0026-2862(74)90066-1. [DOI] [PubMed] [Google Scholar]
  33. Messina E. J., Weiner R., Kaley G. Prostaglandins and local circulatory control. Fed Proc. 1976 Oct;35(12):2367–2375. [PubMed] [Google Scholar]
  34. Moncada S., Gryglewski R. J., Bunting S., Vane J. R. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins. 1976 Nov;12(5):715–737. doi: 10.1016/0090-6980(76)90048-4. [DOI] [PubMed] [Google Scholar]
  35. Moncada S., Herman A. G., Higgs E. A., Vane J. R. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res. 1977 Sep;11(3):323–344. doi: 10.1016/0049-3848(77)90185-2. [DOI] [PubMed] [Google Scholar]
  36. Needleman P., Bronson S. D., Wyche A., Sivakoff M., Nicolaou K. C. Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues. J Clin Invest. 1978 Mar;61(3):839–849. doi: 10.1172/JCI108998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nowak J., Kaijser L., Wennmalm A. Cardiac synthesis of prostaglandins from arachidonic acid in man. Prostaglandins Med. 1980 Apr;4(4):205–214. doi: 10.1016/0161-4630(80)90015-4. [DOI] [PubMed] [Google Scholar]
  38. Ogino N., Miyamoto T., Yamamoto S., Hayaishi O. Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. J Biol Chem. 1977 Feb 10;252(3):890–895. [PubMed] [Google Scholar]
  39. Omini C., Moncada S., Vane J. R. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S). Prostaglandins. 1977 Oct;14(4):625–632. doi: 10.1016/0090-6980(77)90189-7. [DOI] [PubMed] [Google Scholar]
  40. Parks T. P., Printz M. P. Prostaglandin endoperoxide D-isomerase activity in vascular tissue. Adv Prostaglandin Thromboxane Res. 1980;7:711–713. [PubMed] [Google Scholar]
  41. Phillips P., Kumar P., Kumar S., Waghe M. Isolation and characterization of endothelial cells from rat and cow brain white matter. J Anat. 1979 Sep;129(Pt 2):261–272. [PMC free article] [PubMed] [Google Scholar]
  42. Rosenblum W. I., El-Sabban F. Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse. Stroke. 1979 Jul-Aug;10(4):399–401. doi: 10.1161/01.str.10.4.399. [DOI] [PubMed] [Google Scholar]
  43. Ryan J. W., Chung A., Ryan U. S. Angiotensin-converting enzyme: I. New strategies for assay. Environ Health Perspect. 1980 Apr;35:165–170. doi: 10.1289/ehp.8035165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sherer G. K., Fitzharris T. P., Faulk W. P., LeRoy E. C. Cultivation of microvascular endothelial cells from human preputial skin. In Vitro. 1980 Aug;16(8):675–684. doi: 10.1007/BF02619197. [DOI] [PubMed] [Google Scholar]
  45. Siess W., Dray F., Seillan C., Ody C., Russo-Marie F. Prostanoid synthesis by vascular slices and cultured vascular cells of piglet aorta. Biochem Biophys Res Commun. 1981 Mar 31;99(2):608–616. doi: 10.1016/0006-291x(81)91788-5. [DOI] [PubMed] [Google Scholar]
  46. Simionescu M., Simionescu N. Isolation and characterization of endothelial cells from the heart microvasculature. Microvasc Res. 1978 Nov;16(3):426–452. doi: 10.1016/0026-2862(78)90074-2. [DOI] [PubMed] [Google Scholar]
  47. Skidgel R. A., Printz M. P. PGI2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries. Prostaglandins. 1978 Jul;16(1):1–16. doi: 10.1016/0090-6980(78)90196-x. [DOI] [PubMed] [Google Scholar]
  48. Tai H. H., Yuan B. A simple and sensitive assay for 9-hydroxyprostaglandin dehydrogenase. Anal Biochem. 1977 Apr;78(2):410–422. doi: 10.1016/0003-2697(77)90102-6. [DOI] [PubMed] [Google Scholar]
  49. VanRollins M., Ho S. H., Greenwald J. E., Alexander M., Dorman N. J., Wong L. K., Horrocks L. A. Complete separation by high performance liquid chromatography of metabolites of arachidonic acid from incubation with human and rabbit platelets. Prostaglandins. 1980 Sep;20(3):571–577. doi: 10.1016/0090-6980(80)90044-1. [DOI] [PubMed] [Google Scholar]
  50. Wagner R. C., Matthews M. A. The isolation and culture of capillary endothelium from epididymal fat. Microvasc Res. 1975 Nov;10(3):286–297. doi: 10.1016/0026-2862(75)90033-3. [DOI] [PubMed] [Google Scholar]
  51. Weksler B. B., Marcus A. J., Jaffe E. A. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3922–3926. doi: 10.1073/pnas.74.9.3922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Williams T. J. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol. 1979 Mar;65(3):517–524. doi: 10.1111/j.1476-5381.1979.tb07860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wong P. Y., Lee W. H., Chao P. H., Reiss R. F., McGiff J. C. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification. J Biol Chem. 1980 Oct 10;255(19):9021–9024. [PubMed] [Google Scholar]
  54. Zetter B. R. The endothelial cells of large and small blood vessels. Diabetes. 1981;30(Suppl 2):24–28. doi: 10.2337/diab.30.2.s24. [DOI] [PubMed] [Google Scholar]
  55. de Deckere E. A., Nugteren D. H., Ten Hoor F. Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart. Nature. 1977 Jul 14;268(5616):160–163. doi: 10.1038/268160a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES